Literature DB >> 34470489

Thrombectomy in Extensive Stroke May Not Be Beneficial and Is Associated With Increased Risk for Hemorrhage.

Lukas Meyer1, Matthias Bechstein1, Maxim Bester1, Uta Hanning1, Caspar Brekenfeld1, Fabian Flottmann1, Helge Kniep1, Noel van Horn1, Milani Deb-Chatterji2, Götz Thomalla2, Peter Sporns1,3, Leonard Leong-Litt Yeo4,5, Benjamin Yong-Qiang Tan4,5, Anil Gopinathan6,5, Andreas Kastrup7, Maria Politi8, Panagiotis Papanagiotou8,9, André Kemmling10,11, Jens Fiehler1, Gabriel Broocks1.   

Abstract

Background and Purpose: This study evaluates the benefit of endovascular treatment (EVT) for patients with extensive baseline stroke compared with best medical treatment.
Methods: This retrospective, multicenter study compares EVT and best medical treatment for computed tomography (CT)–based selection of patients with extensive baseline infarcts (Alberta Stroke Program Early CT Score ≤5) attributed to anterior circulation stroke. Patients were selected from the German Stroke Registry and 3 tertiary stroke centers. Primary functional end points were rates of good (modified Rankin Scale score of ≤3) and very poor outcome (modified Rankin Scale score of ≥5) at 90 days. Secondary safety end point was the occurrence of symptomatic intracerebral hemorrhage. Angiographic outcome was evaluated with the modified Thrombolysis in Cerebral Infarction Scale.
Results: After 1:1 pair matching, a total of 248 patients were compared by treatment arm. Good functional outcome was observed in 27.4% in the EVT group, and in 25% in the best medical treatment group (P=0.665). Advanced age (adjusted odds ratio, 1.08 [95% CI, 1.05–1.10], P<0.001) and symptomatic intracerebral hemorrhage (adjusted odds ratio, 6.35 [95% CI, 2.08–19.35], P<0.001) were independently associated with very poor outcome. Mortality (43.5% versus 28.9%, P=0.025) and symptomatic intracerebral hemorrhage (16.1% versus 5.6%, P=0.008) were significantly higher in the EVT group. The lowest rates of good functional outcome (≈15%) were observed in groups of failed and partial recanalization (modified Thrombolysis in Cerebral Infarction Scale score of 0/1–2a), whereas patients with complete recanalization (modified Thrombolysis in Cerebral Infarction Scale score of 3) with recanalization attempts ≤2 benefitted the most (modified Rankin Scale score of ≤3:42.3%, P=0.074) compared with best medical treatment. Conclusions: In daily clinical practice, EVT for CT–based selected patients with low Alberta Stroke Program Early CT Score anterior circulation stroke may not be beneficial and is associated with increased risk for hemorrhage and mortality, especially in the elderly. However, first- or second-pass complete recanalization seems to reveal a clinical benefit of EVT highlighting the vulnerability of the low Alberta Stroke Program Early CT Score subgroup. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT03356392.

Entities:  

Keywords:  hemorrhage; risk; stroke; thrombectomy

Mesh:

Year:  2021        PMID: 34470489     DOI: 10.1161/STROKEAHA.120.033101

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Predictors of symptomatic intracranial hemorrhage after endovascular treatment for acute large vessel occlusion: data from ANGEL-ACT registry.

Authors:  Dapeng Sun; Xiaochuan Huo; Baixue Jia; Xu Tong; Gaoting Ma; Anxin Wang; Ning Ma; Feng Gao; Dapeng Mo; Zhongrong Miao
Journal:  J Thromb Thrombolysis       Date:  2022-08-01       Impact factor: 5.221

2.  Venous Outflow Profiles Are Linked to Clinical Outcomes in Ischemic Stroke Patients with Extensive Baseline Infarct.

Authors:  Laurens Winkelmeier; Gabriel Broocks; Helge Kniep; Vincent Geest; Jonathan Reinwald; Lukas Meyer; Noel van Horn; Adrien Guenego; Kamil Zeleňák; Gregory W Albers; Maarten Lansberg; Peter Sporns; Max Wintermark; Jens Fiehler; Jeremy J Heit; Tobias D Faizy
Journal:  J Stroke       Date:  2022-09-30       Impact factor: 8.632

3.  The Benefit of Thrombectomy in Patients With Low ASPECTS Is a Matter of Shades of Gray-What Current Trials May Have Missed.

Authors:  Gabriel Broocks; Lukas Meyer; Rosalie McDonough; Matthias Bechstein; Uta Hanning; Jens Fiehler; Andre Kemmling
Journal:  Front Neurol       Date:  2022-01-14       Impact factor: 4.003

4.  Editorial: Mechanisms, Measurement, and Management of Vasogenic Edema After Stroke.

Authors:  Gabriel Broocks; Jens Minnerup; Shervin Kamalian; Andre Kemmling
Journal:  Front Neurol       Date:  2022-02-24       Impact factor: 4.003

5.  Mechanical Thrombectomy: Review.

Authors:  Chintan Prajapati; Vikram Huded; Niranjan Mahajan; Anirudh Kulkarni
Journal:  Ann Indian Acad Neurol       Date:  2022-06-09       Impact factor: 1.714

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.